GlassScriptPhysician profile
Thomas Jefferson Hicks
NPI 1740292713
$5,200.29
in general payments reported to CMS, 2019-2025
16 companies · $617 in 2025
The $617 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $80.35 · 2021: $380 · 2022: $1,249 · 2023: $1,512 · 2024: $682 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,810.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,663.08 | 2019-2024 | Amo Phaco Needle, One Series Ultra, Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $418.21 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $359.59 | 2023-2025 | Syfovre |
| Bausch & Lomb Americas INC. | $334.52 | 2023-2025 | Miebo, Xiidra |
| Alcon Vision LLC | $225.29 | 2022-2023 | Precision 1, Dailies Total1, Total30 |
| Dompe US, INC. | $163.66 | 2023-2025 | Oxervate |
| Optos, INC. | $134.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $133.20 | 2019 | |
| Allergan, INC. | $124.74 | 2022 | |
| Harrow Eye, LLC | $123.50 | 2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $120.54 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $119.51 | 2025 | Xdemvy |
| Glaukos Corporation | $110.57 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $69.36 | 2023 | Cequa |
| Abbvie INC. | $55.65 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $44.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.